The last two decades have witnessed an increase in sepsis following transrectal prostate biopsy (TRPB), predominantly due to a rise in fluoroquinolone resistance. As a result, numerous strategies have been proposed to decrease sepsis related complications. We assessed our institutional trends for biopsy related complications following the implementation of augmented antibiotics, rectal swab culture-directed antibiotics, and use of formalin needle disinfectant technique.
INTRODUCTION AND OBJECTIVES:
The last two decades have witnessed an increase in sepsis following transrectal prostate biopsy (TRPB), predominantly due to a rise in fluoroquinolone resistance. As a result, numerous strategies have been proposed to decrease sepsis related complications. We assessed our institutional trends for biopsy related complications following the implementation of augmented antibiotics, rectal swab culture-directed antibiotics, and use of formalin needle disinfectant technique.
METHODS: Patients undergoing TRPB were identified by reviewing a prospectively maintained clinical registry. The use of augmented antibiotics and rectal swab culture-directed antibiotics was introduced in 2013. Formalin needle disinfectant technique following each biopsy core was introduced in 2016. To evaluate the impact of these techniques on morbidity, post-biopsy complication rates following implementation of augmented and culture-directed prophylaxis (2013) (2014) (2015) and after addition of formalin needle disinfectant technique (2016) were compared to complication rates prior to modification of our biopsy protocol (2012) .
RESULTS: A total of 2,549 patients underwent TRPB during a 5 year period. In 2012, prior to protocol modification, infectious complications occurred in 1.9% of patients, consisting of sepsis in 0.63%, UTI in 0.63%, and post-biopsy fever in 0.63%. Following the introduction of rectal swabs and augmented antibiotics in 2013, 63.23% of patients received culture-directed antibiotics and 13.7% received augmented IV/IM prophylaxis. Between 2013 and 2015, sepsis, UTI, and post-biopsy fever rates were 0.28% (p=0.29), 0.98% (p=0.75), and 1.54% (p=0.29), respectively. In 2016, following implementation of both rectal swabs and formalin needle disinfectant technique, rates of sepsis, UTI, and post-biopsy fever were 0.00% (p=0.08), 0.37% (p=0.62), and 1.24% (p=0.53), respectively. A time trend analysis of complication rates is provided in Figure 1 .
CONCLUSIONS: Following incorporation of both culture-directed antibiotics and formalin needle disinfectant technique, a trend towards decreased sepsis rates (0.00%, p=0.08) was achieved at our institution. This regimen thus has the potential to dramatically reduce or eliminate post-biopsy sepsis. Source of Funding: None
